Marina Ramus

Marina Ramus

Auto-generated profile, based on publicly available information

Marina Ramus

Microbiology and Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2023 in Eurosurveillance
Verified
Journal Article
Open access
IMIrene Mileto
Irene Mileto
GPGreta Petazzoni
Greta Petazzoni
MCMarta Corbella
Marta Corbella
SGStefano Gaiarsa
Stefano Gaiarsa
CMCristina Merla
Cristina Merla
Fausto BaldantiFausto Baldanti
Fausto Baldanti
New Delhi metallo-beta-lactamase (NDM)-producing Klebsiella pneumoniae (Kp) ST147 caused a large multi-hospital outbreak in Italy from 2018 to 2021. We describe a new ST6668 NDM-producing Kp clone, belonging to CC147, which rapidly spread across hospitals in the Pavia province (Northern Italy) from February to August 2023. Genomic analyses revealed that ST6668 is different from ST147 and fast evolving. As shown here, genomic surveillance programmes are useful for tracking the spread of new clones with reduced susceptibility to most antibiotics.

6 May 2025 in Journal of Medical Virology
Verified
Journal Article
Closed access
FGFederica Giardina
Federica Giardina
SPStefania Paolucci
Stefania Paolucci
DMDalila Mele
Dalila Mele
OMOmar Mura
Omar Mura
MRMarina Ramus
Marina Ramus
Fausto BaldantiFausto Baldanti
Fausto Baldanti

26 February 2026 in Journal of Infection and Public Health
Verified
Journal Article
Open access
GPGreta Petazzoni
Greta Petazzoni
SGStefano Gaiarsa
Stefano Gaiarsa
IMIrene Mileto
Irene Mileto
AKAngela Kuka
Angela Kuka
MCMarta Corbella
Marta Corbella
Fausto BaldantiFausto Baldanti
Fausto Baldanti
Healthcare-associated infections (HAIs) in Europe affect millions of patients annually, driving antimicrobial resistance and imposing significant economic burdens. Carbapenem-resistant Enterobacterales (CRE) are particularly concerning due to their ability to spread, making genomic surveillance essential for tracking their transmission. From October 2022 to September 2023, we sequenced and analysed the genome of 340 CRE obtained from patients admitted to Fondazione IRCCS Policlinico San Matteo ( Italy). Sequencing was performed using a short-read approach and genomes were in-silico characterized to identify Sequence Types (STs), antimicrobial resistance and virulence determinants, and plasmid content. Moreover, a core SNP-based phylogeny was performed to identify potential epidemic clusters within the same clone. Among the 340 CRE isolated from surveillance (N = 234) and other clinical specimens (N = 106), 87.7% belonged to the Klebsiella genus, primarily K. pneumoniae (CR-Kp, N = 284). Escherichia coli (CR-Ec) accounted for 8.5% (N = 29); while the remaining species were Enterobacter spp. (N = 13) and Citrobacter spp. (N = 9). blaKPC and blaNDM gene variants were detected in 55.9% and 25.6% of CRE, respectively. The most prevalent CR-Kp clones were ST307, ST6668, ST258, and ST512, whereas ST131 was dominant among CR-Ec. Large epidemic clusters (ECs; ≥ 5 strains in each clade) were mainly found in CR-Kp associated with ST307 and ST6668, with 80.63% of CR-Kp grouped into nine ECs. Conversely, other species were observed as sporadic cases or within transmission clusters with limited spread. Our comprehensive analysis of CRE circulation at HSM revealed that their dissemination was largely driven by highly successful clones, shedding light on several of them.